Expanded A.I. and machine learning capabilities will accelerate Mydecine’s broader research and development efforts
June 16, 2021
Ryan Allway June 16th, 2021 Psychedelics DENVER, June 16, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced the launch of... Read more
